---
document_datetime: 2025-07-31 16:15:42
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/saxenda-epar-all-authorised-presentations_en.pdf
document_name: saxenda-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8946348
conversion_datetime: 2025-12-19 03:06:58.426951
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| <EMA procedure number> <MA (EU) number>   | (Invented) name   | Strength   | Pharmaceutical form    | Route of administration   | Immediate Packaging                  | <Content (concent ration)>   | Pack size         |
|-------------------------------------------|-------------------|------------|------------------------|---------------------------|--------------------------------------|------------------------------|-------------------|
| EU/1/15/992/001                           | Saxenda           | 6 mg/ml    | Solution for injection | Subcutaneous use          | cartridge (glass) in pre- filled pen | 3 ml                         | 1 pre-filled pen  |
| EU/1/15/992/002                           | Saxenda           | 6 mg/ml    | Solution for injection | Subcutaneous use          | cartridge (glass) in pre- filled pen | 3 ml                         | 3 pre-filled pens |
| EU/1/15/992/003                           | Saxenda           | 6 mg/ml    | Solution for injection | Subcutaneous use          | cartridge (glass) in pre- filled pen | 3 ml                         | 5 pre-filled pens |